Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
Tiziana Life Sciences Plc |
LSE:TILS |
London |
Ordinary Share |
GB00BKWNZY55 |
ORD 3P |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
1.00 |
0.96% |
105.00 |
107.00 |
110.00 |
112.50 |
103.50 |
103.50 |
1,326,160 |
16:35:13 |
Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
Pharmaceuticals & Biotechnology |
0.0 |
-7.8 |
-5.4 |
- |
204 |
Tiziana Life Sciences Share Discussion Threads

Showing 12751 to 12772 of 14825 messages
Date | Subject | Author | Discuss |
---|
24/1/2021 18:59 | Don’t bother fan, a hopeless case. |  stenick | |
24/1/2021 18:55 | When we hit £10 i will start a crowd fund page for REBS rehab.... |  fandagle | |
24/1/2021 18:52 | Yeah Rebel I heard about you, always putting down and spreading rumours, like be careful don’t believe what you here, yeah right, apparently CSO’s and CEO’s can lie through their teeth and get away with it without repercussions. As if, grow up ,smell the coffee,and stump up a good offer. |  stenick | |
24/1/2021 18:24 | Hehe, still brimming with an abundance of incompetence hey Mark0419...never mind ehh!
...I think its all becoming extremely clear now with the 'Tool that is the Fool'! |  rebelwithacause1 | |
24/1/2021 18:20 | Rebelwithoutabrain is flying out to see his shrink, he got multiple personality syndrome. Hehe |  mark0419 | |
24/1/2021 18:11 | Apparently...doctors, nurses, patients all say it works - really!
...Shall we twist the truth even further, now seems like an opportune time! |  rebelwithacause1 | |
24/1/2021 18:11 | I worked in Mauritias for a month in January 2002, it was the most beautiful place in the world.... |  fandagle | |
24/1/2021 17:07 | We took the kids there numerous times, loved it , won’t knock it. |  stenick | |
24/1/2021 17:02 | I got married there |  markstevenkirby80 | |
24/1/2021 17:00 | Ride on mate.I like Florida many good memories. |  stenick | |
24/1/2021 16:55 | Enjoy! I'm traveling south to Florida this coming week, not much Lockdown there ;o-) |  yidarmytom | |
24/1/2021 16:34 | Just seen the webcast, doctors nurses patient all saying ‘it works’ what’s not to like.Fireside chat well ‘can you feel the heat’ . Soooon, they will have to make up their minds, buy or not, we have enough cash to prove proof of concept. GLA.
Flying out now for a year in the Maldives. |  stenick | |
24/1/2021 15:46 | Sure is, we just cannot say with any real confidence which way! |  rebelwithacause1 | |
24/1/2021 15:22 | Next week is bound to be exciting, plenty of coverage here on American Bulletin Boards as the suspense mounts - there could be setbacks as there ALWAYS is with drug development, but if the efficacy, tox data is good, the safety profile is good and the trial met its Primary Endpoint that is usually good enough to expand the trial, once all the data has been peer reviewed. |  yidarmytom | |
24/1/2021 12:43 | Cup and Handle forming lol - again it just proves your incompetence buddy...
Stick to doing what you do best Mark0419/OldApache, being a Tool that is a Fool! |  rebelwithacause1 | |
24/1/2021 12:32 | Such delight or should it be incompetence you bring Mark0419 - never mind ehh! |  rebelwithacause1 | |
24/1/2021 12:31 | Won't be long before our accustem shares will be listed all looking good.Got 20,000 plus of these beauties. |  mark0419 | |
24/1/2021 11:59 | Dont engage hey Tom, I think you'll find you 'Avoid the Question/s' my dear friend not me!
I dont need to demonstrate your incompetence Mark0419/OldApache as it's clear to see on both boards...is it not hehe! |  rebelwithacause1 | |
24/1/2021 11:39 | Totally agree Tom. Looking forward to the week ahead there's got to be a big RNS due soon. Going by the fireside chat. He was so upbeat talking. |  mark0419 | |
24/1/2021 11:26 | Mark041924 Jan '21 - 11:24 - 12669 of 12670
Great Summary and yes, I like that simple concise Redchip web-page |  yidarmytom | |
24/1/2021 11:26 | agree mark,he's Troll to be ignored. I did start to engage and discuss the potential pitfalls of Biotech Investing but then he just starts ranting. For someone who claims to have a Long position here he seems very negative about the Co's prospects, so negative in fact I can't understand why he's invested, although that's probably because he isn't!
The other thing you've no doubt noticed is that as soon as we get a raft of good news and significant increases in the share price Rebs, IVAN, small crow & munchkin all show up en masse, which tells you all you need to know!!
Looking forward to the Covid data next week. Positive data and a much larger trial is the way I expect it to go, with a potential positive effect on the share price. |  yidarmytom | |
24/1/2021 11:24 | https://www.tlsainfo.com/........................................'Investment Highlights........................................ Transformational platform technologiesProprietary oral, nasal and inhaled formulation technologies to transform immunotherapies with Monoclonal Antibodies currently administered intravenouslyPhase 2 oral immunotherapy study for Crohn's Disease (CD)Phase 2 clinical study with orally administered Foralumab, a fully human anti-CD3 mAbReporting top-line data from COVID-19 trial in Jan. 2021Innovative technology enables direct delivery of anti-IL6 receptor monoclonal antibodies into the lung using a handheld inhaler or nebulizerPositive anecdotal feedback from recently completed trialCould be effective against SARS, MERS, and all variants of coronavirusesStrong intellectual property protections174 foreign patents and 19 U.S. patents issuedProven leadership team with 'bench to market' experienceEntrepreneurial success in biotech deals; CEO is co-founder, Synergy Pharma; Executive Chairman founded and chaired two biotechs with $2B+ market caps. Exemplary scientific advisory board with world renowned key opinion leadersCollaboration with Parexel Biotech to conduct Phase 1b/2 clinical trial in Chron's patientsSuccessfully spun off StemPrintER business in Q4 2020' |  mark0419 | |